US Stock MarketDetailed Quotes

ASLN Aslan Pharmaceuticals

Watchlist
  • 0.4153
  • -0.0327-7.30%
Close Apr 26 16:00 ET
  • 0.4250
  • +0.0097+2.34%
Post 19:06 ET
9.40MMarket Cap-151P/E (TTM)

About Aslan Pharmaceuticals Company

Aslan Pharmaceuticals Ltd. is a clinical-stage immunology biopharmaceutical company, which develops novel therapeutics. It focuses on atopic dermatitis, other immunology indications and autoimmune disease. Its pipeline includes ASLAN003 and Eblasakimab. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Company Profile

SymbolASLN
Company NameAslan Pharmaceuticals
Listing DateMay 4, 2018
Issue Price7.03
Founded2010
CEODr. Carl Firth, PhD
MarketNASDAQ
Employees35
Securities TypeDR
ADS Ratio1.0 : 25.0
Fiscal Year Ends12-31
Address3 Temasek Avenue,18 Level Centennial Tower
CitySingapore
ProvinceCentral Singapore
CountrySingapore
Zip Code039190
Phone65-6817-9598
Websitehttp://www.aslanpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Carl Firth, PhD
  • Director and Chief Executive Officer
  • --
  • Kiran Asarpota
  • Chief Operating Officer and Head of Finance
  • --
  • Dr. Alexandre Kaoukhov, M.D.
  • Chief Medical Officer
  • --
  • Stephen Doyle
  • Chief Business Officer
  • --
  • Andrew Howden
  • Chairman of the Board
  • 92.38K
  • Dr. Kathleen M. Metters, PhD
  • Independent Director
  • 58.50K
  • Dr. Neil Graham, M.B.B.S.,M.D.,M.P.H.
  • Independent Director
  • 66.29K
  • Robert E. Hoffman, C.P.A.
  • Independent Director
  • 63.25K
  • Ben Goodger
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg